Sep 28

SS 15 - Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC

173 - C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival

11:05am - 11:15am ET

Screen: 7

Presenter(s)

Sandro Porceddu, MD - Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC